Rezolute (RZLT) Cash from Operations (2010 - 2026)
Rezolute (RZLT) posted Cash from Operations of 13689000.0 for Q1 2026, up 32.9% sequentially from 20400000.0 in Q4 2025, and up 21.33% YoY from 11282677.28 in Q1 2025.
Powered by 
Analysis
Rezolute (RZLT) Cash from Operations (2010 - 2026) Analysis & Trends
Rezolute has reported Cash from Operations for 17 years, with the latest figure at 13689000.0 in Q1 2026.
- Quarterly Cash from Operations rose 21.33% year-over-year to 13689000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 73509000.0 (down 12.05% YoY) and the FY2025 annual result came in at 69100000.0, down 20.45% from the prior year.
- Cash from Operations advanced to 13689000.0 in Q1 2026 per RZLT's latest filing, from 20400000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 7493000.0 in Q4 2022 and troughed at 22020000.0 in Q2 2025.
- A 5-year average of 14618588.24 and a median of 13968000.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2026: Cash from Operations tumbled 158.81% in 2022, then rose 21.33% in 2026.
- Over 5 years, Cash from Operations stood at 7493000.0 in 2022, then plunged by 73.76% to 13020000.0 in 2023, then declined by 4.96% to 13666000.0 in 2024, then plunged by 49.28% to 20400000.0 in 2025, then soared by 32.9% to 13689000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 13689000.0, 20400000.0, and 17400000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - | -13.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -13.70 Mn |
| Dec 31, 2025 | -20.37 Mn |
| Sep 30, 2025 | -17.43 Mn |
| Jun 30, 2025 | -22.02 Mn |
| Mar 31, 2025 | -17.40 Mn |
| Dec 31, 2024 | -13.67 Mn |
| Sep 30, 2024 | -16.01 Mn |
| Jun 30, 2024 | -18.52 Mn |
| Mar 31, 2024 | -15.24 Mn |
| Dec 31, 2023 | -13.02 Mn |
| Sep 30, 2023 | -10.59 Mn |
| Jun 30, 2023 | -11.35 Mn |
| Mar 31, 2023 | -18.05 Mn |
| Dec 31, 2022 | -7.49 Mn |
| Sep 30, 2022 | -7.59 Mn |
| Jun 30, 2022 | -12.11 Mn |
| Mar 31, 2022 | -13.97 Mn |
| Dec 31, 2021 | -7.20 Mn |
| Sep 30, 2021 | -6.34 Mn |
| Jun 30, 2021 | -5.23 Mn |